Friday, 22 May 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 22 May 2026
Ascott 2
Ascott 2
Who's ready for a June PBS listing?

Some big names are contenders for a June PBS listing, with seven drugs sitting in the last stage before reimbursement and another three drugs just a step behind.

Ex-Google boss busts pharma silos
Free invitation-only roundtable series will tackle the issue of functional silos in pharma with help from an ex-Google chief
TODAY
Legacy brand hits new heights
Drug secures category win and the nation's second most trusted brand across all categories, marking its highest ever overall ranking
TODAY
Medscape
Medscape
Highest paid KOLs revealed
Meet the KOLs earning the highest payments from Aussie pharma and the fresh crop of influential voices who have joined the list
21 May
High-flyer exits corporate world
After almost five years in a Big Pharma role, this executive said she's chosen to leave corporate life to "fly a little further"
21 May
New CEO announced after 2 years
After the passing of the Aussie biotech's CEO and Co-Founder in 2024, a former academic turned strategic investment consultant has taken the helm
21 May
Drug pulled after less than 3 years
This company has officially pulled its drug from the Australian market, as of today, rather than pursuing full registration
20 May
ADG PRIME
ADG PRIME
Latest Jobs
Second drug carves out new niche
Another company carves out a new niche in a drug class previously exclusively approved for haematological malignancies
21 May
Govt warns pharmacists over PBS
The Dept has issued a warning against charging private scripts to the PBS, adding there are penalties for the unlawful behaviour
21 May
Pharma spend on HCPs doubles
The 10 companies spending the most on HCPs forked out a total of $11.5M in just seven months, with six spending $1M-plus each
20 May
Obesity drugs now gold standard
Heart Foundation includes weight loss drugs in its new guidance for treating obesity and reducing the risk of heart attack or stroke
20 May
Drugs battle for US$2.7B market
The pending launch of five new drugs will disrupt this growing market which is currently dominated by a single treatment
20 May
Big demand for hot ticket event
A free virtual event being held today has attracted 550-plus registrants and counting to discuss industry's most pressing issues
20 May
Which Drs really distrust pharma?
Four out of five Millennial doctors have a negative view of pharma, and they're about to become the biggest cohort of clinicians
19 May
World's Most Innovative Pharma is...
Company named the world's most innovative pharma for developing a drug which could herald the end of this disease
19 May
Should biosims be the default?
Sandoz has welcomed a Commonwealth consultation into making biosimilars the default when prescribing new medicines
19 May
Global Head issues Aussie warning
Visiting Sanofi leader has warned of the risks to Australia if we fail to speed up access to medicines and vaccines
19 May
Wait time blows out to 3.6 years
Industry's peak body warns that ballooning "bureaucratic delays" is leading some drug makers to abandon the jurisdiction
19 May
Inside Aussie Med Affairs salaries
This survey takes a deep dive into the pay packets of Medical Affairs staffers across the world, including Australia
18 May
Aussie GM steps up to regional role
Less than 18 months after taking the ANZ General Manager role, a major promotion for this high-flyer with hunt on for a successor
18 May
Health PR agency snaps up Award
Australian firm well known to pharma has taken home an Asia Pacific gong after speedrunning a brief from the United Nations
18 May
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.